Lantern Pharma Inc. (LTRN): Depreciation & Amortization
$17.3K
Year ended 2025-12-31
$15.8K
Trailing 12 months to 2026-06-30
+19.7%
3-year compound annual growth
+38.5%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.3K | 0.0% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $17.3K | +18.2% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $14.6K | +45.0% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $10.1K | +49.1% | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | $6.8K | +99.6% | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | $3.4K | +108.2% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $1.6K | n/a | 2021-03-10, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $17.3K | 0.0% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $7.2K | +61.6% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $55.0K | -86.7% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $61.0K | +408.3% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $290.1K | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | $800.0K | +14.3% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $52.7K | +11.1% |
| Imunon, Inc. (IMNN) | 2024-12-31 | $240.0K | -3.2% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $72.0K | -42.9% |
Compare LTRN, DCOY, NCEL, TRAW side by side · Screen every company in Pharmaceutical Preparations ↗